Exercise News and Research

Latest Exercise News and Research

Valensa enters agreement with Mercola for Flex Pro ES formulation

Valensa International and Mercola Health Resources, LLC announced today that they have entered into a license and supply agreement that provides Mercola Health Resources with Valensa's new Flex Pro ES(TM) joint health formulation.

21 Oct 2010

FDA issues complete response letter for BYDUREON NDA

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for BYDUREON™ (exenatide extended-release for injectable suspension).

21 Oct 2010

Genzyme third quarter revenue increases to $1.0 billion

Genzyme Corp. today reported third-quarter earnings growth driven by increased shipments of Cerezyme® (imiglucerase for injection). Patients in the United States began returning to normal dosing levels last month, and patients globally are expected to be able to do so this quarter. Earnings growth in the third quarter was also driven by strong revenue from Lumizyme™ (alglucosidase alfa) and cost reduction measures.

21 Oct 2010

New book on Alzheimer's epidemic

Providing meaningful roles in society, involving children, and embracing a love-based approach are how America can successfully cope with the soaring numbers of people with Alzheimer's, Parkinson's and other memory-impairing diseases. That's the view of Alzheimer's futurists Loren Shook and Steve Winner, who say the nation must elevate care for those with the disease alongside the ongoing efforts to develop prevention and cure measures.

20 Oct 2010

Cell Therapeutics enters agreement to sell $21.0 million of Series 7 Preferred Stock

Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell, subject to customary closing conditions, $21.0 million of shares of its Series 7 Preferred Stock and warrants to purchase shares of its common stock in a registered offering to four institutional investors.

20 Oct 2010

Study shows impaired insulin sensitivity may serve as mediator between obesity and cognitive decline

Because of impairments in their insulin sensitivity, obese individuals demonstrate different brain responses than their normal-weight peers while completing a challenging cognitive task, according to new research by psychologists at The University of Texas at Austin.

20 Oct 2010

OncoGenex announces pricing of public offering

OncoGenex Pharmaceuticals, Inc. today announced that it has priced a public offering of 3,174,602 units, with each unit consisting of one share of the Company's common stock and one-half (1/2) of one warrant, at a purchase price of $15.75 per unit for an aggreate offering amount of $50 million.

20 Oct 2010

ASBP reviews current rules of prescription medication to treat obesity in Kansas

In response to the alarming increase in the overweight and obese population in Kansas, a representative of the American Society of Bariatric Physicians (ASBP) recently testified to the Kansas State Board of Healing Arts. ASBP is America's oldest and most experienced society devoted to the medical treatment of overweight and obesity and associated health conditions and risks.

20 Oct 2010

Cybex third quarter net sales increases to $29.2 million

Cybex International, Inc., a leading manufacturer of premium exercise equipment, today reported results for its third quarter ended September 25, 2010. Net sales for the third quarter of 2010 were $29.2 million compared to $29.0 million for the corresponding 2009 period. The Company reported a net loss for the third quarter of 2010 of $15,000, or $0.00 per diluted share, compared to net income of $81,000, or $0.00 per diluted share, reported for the corresponding 2009 period.

19 Oct 2010

SheKnows City Guide helps women to get expert advice on health

SheKnows one of the fastest growing online content and community global destinations for women, just launched a new city-specific resource titled SheKnows City Guide.

19 Oct 2010

Syneron launches VelaBABE device for women to reclaim pre-baby body

Syneron Medical Ltd., a leading medical aesthetic device innovator, is announcing their new VelaBABE promotion for women who want to reclaim their pre-baby body with help from VelaShape.

19 Oct 2010

Tips to improve cellular prostate health

Prostate cancer is one of the most common cancers in America and may lead to more than 32,000 deaths this year. Medical Doctor and cancer expert, Dr. Isaac Eliaz announces breakthrough research and essential recommendations for the prevention and treatment of prostate cancer.

19 Oct 2010

Moderate amount of protein in low-carb beverage improves aerobic endurance: Report

Compared to a standard carbohydrate supplement, a low-carbohydrate beverage with added protein leads to longer endurance times in cyclists, reports the October issue of the The Journal of Strength and Conditioning Research, official research journal of the National Strength and Conditioning Association.

19 Oct 2010

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

New data on odanacatib, an investigational cathepsin-K (Cat-K) inhibitor in development for the treatment of osteoporosis in postmenopausal women, were presented at the 32nd Annual Meeting of the American Society for Bone and Mineral Research (ASBMR) in Toronto, Canada.

19 Oct 2010

Type 2 diabetes and insulin use associated with CRC risk in men, but not women

There is an association between type 2 diabetes mellitus and colorectal cancer (CRC) among men, but not women, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

19 Oct 2010

UCB presents P3, P4 clinical trial data for Crohn's disease at ACG Scientific Meeting

Findings from the PRECiSE 3 (P3) open label extension study for Cimzia, demonstrating the longest continuously running maintenance trial for an anti-TNF in Crohn's disease, will be exhibited at the 2010 Annual Scientific Meeting of the American College of Gastroenterology (ACG), taking place in San Antonio from October 15 – 20. Additionally, long-term efficacy data from the PRECiSE 4 (P4) clinical trial also will be presented at the meeting.

19 Oct 2010

Studies explore impact of upper GI conditions on sleep

The impact of upper GI conditions, like gastroesophageal reflux disease (GERD) and functional dyspepsia, on sleep—and treatments aimed at providing relief to heartburn/acid reflux patients who suffer from disordered sleep—were explored in three new studies related to sleep dysfunction presented today at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas.

18 Oct 2010

Possibilities of genetics research, personalized medicine, and behavioral intervention

Personalized medicine - improving the fit between patient and treatment - has become a major focus of research in fields from cancer treatment to the psychopharmacology of mental disorders. Genetic studies have suggested that an individual's genetic makeup renders him either more or less sensitive to stressful social environments - but can an individual's unique genotype also determine the effectiveness of preventative or therapeutic behavioral interventions?

18 Oct 2010

Paper presented at HBPR 2010 highlights relationship between BMI and blood pressure in children

The European Society of Cardiology (ESC) welcomes the findings of a paper presented today at the American Heart Association's High Blood Pressure Research 2010 Scientific Sessions (HBPR 2010) held in Washington, DC, USA.

18 Oct 2010

ACG meeting to exhibit Cimzia data for Crohn's disease treatment

Studies and analyses of the Crohn's disease (CD) treatment Cimzia (certolizumab pegol) will be exhibited at the 2010 Annual Scientific Meeting of the American College of Gastroenterology, taking place in San Antonio from October 15 – 20.

18 Oct 2010

Exercise News and Research

Latest Exercise News and Research

Valensa enters agreement with Mercola for Flex Pro ES formulation

FDA issues complete response letter for BYDUREON NDA

Genzyme third quarter revenue increases to $1.0 billion

New book on Alzheimer's epidemic

Cell Therapeutics enters agreement to sell $21.0 million of Series 7 Preferred Stock

Study shows impaired insulin sensitivity may serve as mediator between obesity and cognitive decline

OncoGenex announces pricing of public offering

ASBP reviews current rules of prescription medication to treat obesity in Kansas

Cybex third quarter net sales increases to $29.2 million

SheKnows City Guide helps women to get expert advice on health

Syneron launches VelaBABE device for women to reclaim pre-baby body

Tips to improve cellular prostate health

Moderate amount of protein in low-carb beverage improves aerobic endurance: Report

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

Type 2 diabetes and insulin use associated with CRC risk in men, but not women

UCB presents P3, P4 clinical trial data for Crohn's disease at ACG Scientific Meeting

Studies explore impact of upper GI conditions on sleep

Possibilities of genetics research, personalized medicine, and behavioral intervention

Paper presented at HBPR 2010 highlights relationship between BMI and blood pressure in children

ACG meeting to exhibit Cimzia data for Crohn's disease treatment

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Exercise News and Research

Latest Exercise News and Research

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in